The COVID-19 pandemic continues to evolve in unpredictable ways. Just when it seemed we were gaining control over the virus, another curveball was thrown our way. A recent surge in cases, particularly in New York, coupled with the emergence of a new variant and a decreasing availability of free tests, has once again heightened concerns among public health experts.
The EG-5 Variant: What We Know
One of the primary drivers of the recent increase in cases is the emergence of the EG-5 variant. Scientists have named this variant “ERIS,” and it has rapidly become a significant concern in the public health community due to its increased transmissibility and potential to evade immunity induced by some of the current vaccines, according to a report from CBS News.
The name “ERIS” was not selected arbitrarily. In Greek mythology, Eris is the goddess of discord and strife. Although we hope that the name does not foreshadow the future of this variant, the swift rise in cases associated with it suggests we should be prepared.
Moreover, as noted by Forbes, another variant, Pirola BA.2.86, is also lurking in the background. While the ERIS variant is currently driving the latest wave of COVID-19, Pirola BA.2.86 could potentially exacerbate the situation further.
New York City’s Battle
New York City has been a COVID-19 hotspot since the onset of the pandemic. Recently, the city has experienced a significant surge in cases, with the EG-5 variant being a key contributor. Reports from the New York Post reveal that, alongside this surge, free COVID tests are becoming increasingly difficult to obtain. This lack of testing capacity hinders the ability to monitor the spread and make informed decisions regarding public health policies.
Testing Shortages: A Recurring Issue
History appears to be repeating itself with the shortage of COVID tests. In the early stages of the pandemic, testing was a primary concern. Fast forward a couple of years, and we are witnessing similar scenes: long queues, fully booked appointments, and frustrated residents. This shortage is not merely an inconvenience. Without sufficient testing, tracking the spread of the virus becomes significantly more difficult, potentially leading to further outbreaks and a lack of clarity about the true extent of the problem.
Multiple factors contribute to this shortage. Supply chain disruptions, increased demand due to rising cases, and potential complacency in maintaining large stockpiles of tests, given the previous decline in cases, have all played a role.
A Final Word
We have made significant progress since the beginning of the COVID-19 pandemic. However, the emergence of the EG-5 variant and the recent surge in cases serve as crucial reminders that the battle is far from over. As more details about the EG-5 and Pirola BA.2.86 variants emerge, it is increasingly important for everyone to remain vigilant, informed, and adaptable.